Bipartisan Legislation Links Mental Health and Substance Abuse Resources to the Prescription Drug Monitoring Program
WASHINGTON, D.C. —Today, U.S. Representatives David B. McKinley P.E. (R-W.Va.) and Lisa Blunt Rochester (D-DE) introduced the PDMP Help Patients Act, which will help people suffering from addiction or mental illness locate treatment by linking information on treatment to the states’ prescription drug monitoring program.
“The COVID -19 pandemic has only further fueled our nations opioid epidemic,” said Rep. McKinley. “Now more than ever we should be equipping providers and patients with every resource possible to provide those with substance abuse and mental health disorders the help they need. I am pleased to continue this critical work with Rep. Blunt Rochester to help combat the opioid epidemic.”
“Delaware’s overdose epidemic may have taken more lives in 2020 than any year before. Prescription drug monitoring programs are a critical tool in combatting the on-going overdose epidemic and I’m proud to join my colleague, Congressman McKinley, in helping states enhance their effectiveness so patients in need are immediately connected to treatment,” said Rep. Blunt Rochester.
Attorney General Morrisey Leads Bipartisan Push to Examine FDA